Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltens

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/16/2781746/0/en/Cognition-Therapeutics-Releases-New-Episode-of-Conversations-Podcast-Recorded-at-CTAD-with-Quantitative-EEG-Experts-Drs-Willem-de-Haan-and-Philip-Scheltens.html

PURCHASE, N.Y., Nov. 16, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq:CGTX), (the “Company” or “Cognition”) has released its seventh Conversations video podcast episode: “Quantitative EEG – Effects of CT1812 on Measures of Synaptic Function in Alzheimer’s Disease.” This episode will feature a review and interactive discussion of the results from Cognition’s Phase 2 SEQUEL study, which were presented at the Clinical Trials on Alzheimer’s Disease (CTAD) conference.

Read more at globenewswire.com

Related news for (CGTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.